Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Protein Name: | CUL2 |
Gene Name: | CUL2 |
Protein Full Name: | Cullin-2 |
Alias: | CUL-2; Cullin 2 |
Mass (Da): | 86983 |
Number AA: | 745 |
UniProt ID: | Q13617 |
Locus ID: | 8453 |
COSMIC ID: | CUL2 |
Gene location on chromosome: | 10p11.21 |
Number of cancer specimens: | 19806 |
Percent of cancer specimens with mutations: | 0.53 |
Commentary on involvement of protein in cancer: | Core component of multiple cullin-RING-based ECS (ElonginB/C-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complexes, which mediate the ubiquitination of target proteins. May serve as a rigid scaffold in the complex and may contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. The E3 ubiquitin-protein ligase activity of the complex is dependent on the neddylation of the cullin subunit and is inhibited by the association of the deneddylated cullin subunit with TIP120A/CAND1 By similarity. The functional specificity of the ECS complex depends on the substrate recognition component. ECS(VHL) mediates the ubiquitination of hypoxia-inducible factor (HIF). |